US-COHORT ANALYSIS: FIVE-YEAR OUTCOMES OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER PRESCRIBED ANTIFIBROTICS
Glenn Eiger(Thomas Jefferson University), RAUL LEGUIZAMON, Sadia Benzaquen(Jefferson Einstein Philadelphia Hospital), Maria Helena Siqueira Tavares de Melo, Jose Manuel Martinez Manzano(Brigham and Women's Hospital), Alexander Pappas, Thomas Stavola, Justin Riley Lam, Phuuwadith Wattanachayakul(Einstein Healthcare Network), IRAKLI LEMONJAVA, Andrew Geller, John Malin
Cited by 0
Related Papers
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|105
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia
|American Journal of Respiratory and Critical Care Medicine|2020|82
Single Cell RNA-seq and Mass Cytometry Reveals a Novel and a Targetable Population of Macrophages in Idiopathic Pulmonary Fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|48
Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
|Alimentary Pharmacology & Therapeutics|2024|34
A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin–Proteasome System in Pulmonary Fibrosis
|International Journal of Molecular Sciences|2020|22